Medicare Enrolled
Dr. Jean-Raphael Schneider, M.D.
Neurology · Clearwater, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schneider from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schneider?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schneider
Dr. Jean-Raphael Schneider is a neurology specialist in Clearwater, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schneider performed 42,612 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Schneider received a total of $240,090 from 94 pharmaceutical and/or device companies across 1579 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schneider is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in FL
$240,090 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 96249 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗42,612
Medicare services
Top 2% in FL for neurology
Not available
Unique patients (not deduplicated)
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
22,001 | $5 | $13 |
| Ocrelizumab infusion (Ocrevus) for MS | 16,800 | $42 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
648 | $90 | $164 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
548 | $75 | $142 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
507 | $16 | $73 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
485 | $130 | $220 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
277 | $49 | $233 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
203 | $99 | $472 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
183 | $162 | $350 |
| New patient office visit, complex (60-74 min) | 161 | $164 | $314 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
122 | $140 | $310 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
108 | $187 | $394 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
92 | $95 | $159 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
81 | $109 | $238 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
62 | $12 | $55 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
60 | $4 | $18 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
59 | $20 | $101 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
52 | $3 | $25 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $63 | $111 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 39 | $60 | $114 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
27 | $67 | $129 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $115 | $249 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
26 | $174 | $423 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
41.7% high complexity
52.4% medium
5.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$240,090
Total received (2018-2024)
Avg $34,299/year across 7 years
Top 3% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
94
Companies
1,579
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$24,263
2023
$16,837
2022
$24,018
2021
$15,732
2020
$17,205
2019
$80,515
2018
$61,520
Payments by company (2024)
Alexion Pharmaceuticals, Inc.
$9,377
E.R. Squibb & Sons, L.L.C.
$3,927
ARGENX US, INC.
$3,199
UCB, Inc.
$1,464
Janssen Scientific Affairs, LLC
$1,362
Celgene Corporation
$1,111
ABBVIE INC.
$354
Lilly USA, LLC
$316
TG Therapeutics, Inc.
$293
Lundbeck LLC
$272
Genentech USA, Inc.
$270
Novartis Pharmaceuticals Corporation
$219
PFIZER INC.
$208
Eisai Inc.
$207
GENZYME CORPORATION
$195
Biogen, Inc.
$185
EMD Serono, Inc.
$167
Takeda Pharmaceuticals U.S.A., Inc.
$144
Otsuka America Pharmaceutical, Inc.
$143
CSL Behring
$116
Azurity Pharmaceuticals, Inc.
$114
Amgen Inc.
$114
Neurocrine Biosciences, Inc.
$80
ACADIA Pharmaceuticals Inc
$70
Alnylam Pharmaceuticals Inc.
$53
Sandoz Inc.
$48
Vanda Pharmaceuticals Inc.
$36
MITSUBISHI TANABE PHARMA AMERICA, INC.
$35
Cycle Pharmaceuticals Inc
$23
Grifols USA, LLC
$23
Mallinckrodt Hospital Products Inc.
$21
Merz Pharmaceuticals, LLC
$21
IDORSIA PHARMACEUTICALS US INC
$19
Amylyx Pharmaceuticals, Inc.
$17
Sarepta Therapeutics, Inc.
$17
Averitas Pharma Inc.
$16
Teva Pharmaceuticals USA, Inc.
$14
Becton, Dickinson and Company
$14
Top 3 companies account for 68.0% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$64,604
Alexion Pharmaceuticals, Inc.
$48,144
Genentech USA, Inc.
$46,136
ARGENX US, INC.
$19,011
EMD Serono, Inc.
$17,009
E.R. Squibb & Sons, L.L.C.
$14,420
Celgene Corporation
$5,765
Novartis Pharmaceuticals Corporation
$2,663
Biogen, Inc.
$2,329
UCB, Inc.
$1,551
Alnylam Pharmaceuticals Inc.
$1,397
Janssen Scientific Affairs, LLC
$1,391
Genentech, Inc.
$1,310
Lilly USA, LLC
$854
ABBVIE INC.
$839
Avanir Pharmaceuticals, Inc.
$752
Allergan, Inc.
$723
Amgen Inc.
$722
Lundbeck LLC
$639
AbbVie Inc.
$598
Teva Pharmaceuticals USA, Inc.
$510
Janssen Pharmaceuticals, Inc
$478
Horizon Therapeutics plc
$467
PFIZER INC.
$433
Takeda Pharmaceuticals U.S.A., Inc.
$398
Allergan Inc.
$347
CSL Behring
$327
Supernus Pharmaceuticals, Inc.
$301
TG Therapeutics, Inc.
$293
ARBOR PHARMACEUTICALS, INC.
$292
BANNER LIFE SCIENCES, LLC
$291
Eisai Inc.
$288
Otsuka America Pharmaceutical, Inc.
$283
UPSHER-SMITH LABORATORIES LLC
$264
IMPEL PHARMACEUTICALS INC.
$258
Biohaven Pharmaceuticals, Inc.
$230
GE HEALTHCARE
$212
SANOFI-AVENTIS U.S. LLC
$207
Azurity Pharmaceuticals, Inc.
$183
MITSUBISHI TANABE PHARMA AMERICA, INC.
$166
Acorda Therapeutics, Inc
$155
Upsher-Smith Laboratories LLC
$143
TG THERAPEUTICS, INC.
$135
Neurocrine Biosciences, Inc.
$135
Merz Pharmaceuticals, LLC
$133
Merz North America, Inc.
$128
Grifols USA, LLC
$118
JAZZ PHARMACEUTICALS INC.
$104
Arbor Pharmaceuticals, Inc.
$104
Mitsubishi Tanabe Pharma America, Inc.
$99
ACADIA Pharmaceuticals Inc
$95
Mallinckrodt LLC
$90
CATALYST PHARMACEUTICALS, INC.
$88
Octapharma USA, Inc.
$87
Biohaven Pharmaceutical Holding Company Ltd.
$87
Banner Life Sciences, LLC
$83
Mallinckrodt Hospital Products Inc.
$81
Amylyx Pharmaceuticals, Inc.
$70
EISAI INC.
$66
Sobi, Inc
$63
Collegium Pharmaceutical, Inc.
$59
IDORSIA PHARMACEUTICALS US INC
$56
Bayer HealthCare Pharmaceuticals Inc.
$54
Nevro Corp.
$51
Bausch Health US, LLC
$48
Sandoz Inc.
$48
Amneal Pharmaceuticals LLC
$44
Currax Pharmaceuticals LLC
$41
Xeris Pharmaceuticals, Inc.
$38
Vanda Pharmaceuticals Inc.
$36
Catalyst Pharmaceuticals, Inc.
$36
GE Healthcare
$28
SK Life Science, Inc.
$25
Mallinckrodt Enterprises LLC
$24
Akcea Therapeutics, Inc.
$24
Vertical Pharmaceuticals, LLC
$23
Cycle Pharmaceuticals Inc
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Exeltis, USA Inc.
$21
AstraZeneca Pharmaceuticals LP
$21
Ultragenyx Pharmaceutical Inc.
$21
ASSERTIO THERAPEUTICS, Inc.
$19
GE HealthCare
$17
Medtronic USA, Inc.
$17
Sarepta Therapeutics, Inc.
$17
Egalet US Inc
$17
Averitas Pharma Inc.
$16
Zyla Life Sciences, Inc.
$15
Shire North American Group Inc
$14
Becton, Dickinson and Company
$14
Purdue Pharma L.P.
$13
Almatica Pharma LLC
$13
Assertio Therapeutics, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 66.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · AUBAGIO · Aimovig · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Bard Urinary Drainage Bag · Betaseron · Briviact · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DUOPA · Dayvigo · ELYXYB - celecoxib · EMGALITY · EVUSHELD · Elevidys · Enspryng · Erivedge · Evrysdi · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GIVLAARI · GRALISE · GVOKE PFS · Gamunex-C · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OXTELLAR XR · Ocrevus · Omnia · Ozanimod · PANZYGA · PAXLOVID · PIPELINE-MS · POMPE - DISEASE · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · RELEXXII · RELISTOR · RELYVRIO · REXULTI · REYVOW · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYNCHROMED · Senza · Soliris · TECFIDERA · TEGSEDI · TEPEZZA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XCOPRI · XEOMIN · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
172
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
MEASE COUNTRYSIDE HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schneider is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schneider experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Schneider performed 22,001 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Schneider receive payments from pharmaceutical companies?
Yes. Dr. Schneider received a total of $240,090 from 94 companies across 1,579 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schneider's costs compare to other neurologists in Clearwater?
Dr. Schneider's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schneider) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Clearwater
Browse neurologists in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology